Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Multani

Showing results (421-430 of 462) with videos related to

Pageof 47
Sort By:
Molecular Cancer Therapeutics|October 22, 2017
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> IsoformsKasey L Couts, Judson Bemis, Jacqueline A Turner, et al.
Plos One|March 9, 2016
Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient OutcomesPriscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, et al.
Plos One|September 2, 2015
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient OutcomesPriscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure ProphylaxisAniruddha Hazra, Philip A Chan, Meredith Clement, et al.
Nature|March 25, 2021
Breast tumours maintain a reservoir of subclonal diversity during expansionDarlan C Minussi, Michael D Nicholson, Hanghui Ye, et al.
Indian Pediatrics|January 6, 2024
Consensus Statement of the IAP - Neurodevelopmental Chapter On Neurodevelopmental Disorders Habilitation Process: Strategic Plan for Prevention, Early Detection and Early InterventionM K C Nair, Shabina Ahmed, Kawaljit Singh Multani, et al.
Annals of Neurology|April 5, 2024
Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear PalsyIndira Garcia-Cordero, Chloe Anastassiadis, Abeer Khoja, et al.
Molecular Systems Biology|February 17, 2017
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressuresNicholas A Graham, Aspram Minasyan, Anastasia Lomova, et al.
Lancet (London, England)|November 14, 2021
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddarth Reddy, William Blackwelder, et al.
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Pageof 47

Showing results (421-430 of 462) with videos related to

Sort By:
Pageof 47
Molecular Cancer Therapeutics|October 22, 2017
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> IsoformsKasey L Couts, Judson Bemis, Jacqueline A Turner, et al.
Plos One|March 9, 2016
Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient OutcomesPriscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, et al.
Plos One|September 2, 2015
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient OutcomesPriscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure ProphylaxisAniruddha Hazra, Philip A Chan, Meredith Clement, et al.
Nature|March 25, 2021
Breast tumours maintain a reservoir of subclonal diversity during expansionDarlan C Minussi, Michael D Nicholson, Hanghui Ye, et al.
Indian Pediatrics|January 6, 2024
Consensus Statement of the IAP - Neurodevelopmental Chapter On Neurodevelopmental Disorders Habilitation Process: Strategic Plan for Prevention, Early Detection and Early InterventionM K C Nair, Shabina Ahmed, Kawaljit Singh Multani, et al.
Annals of Neurology|April 5, 2024
Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear PalsyIndira Garcia-Cordero, Chloe Anastassiadis, Abeer Khoja, et al.
Molecular Systems Biology|February 17, 2017
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressuresNicholas A Graham, Aspram Minasyan, Anastasia Lomova, et al.
Lancet (London, England)|November 14, 2021
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddarth Reddy, William Blackwelder, et al.
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Pageof 47